These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
401 related articles for article (PubMed ID: 26386860)
1. Hypermethylation of ACP1, BMP4, and TSPYL5 in Hepatocellular Carcinoma and Their Potential Clinical Significance. Qiu X; Hu B; Huang Y; Deng Y; Wang X; Zheng F Dig Dis Sci; 2016 Jan; 61(1):149-57. PubMed ID: 26386860 [TBL] [Abstract][Full Text] [Related]
2. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma. Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282 [TBL] [Abstract][Full Text] [Related]
3. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma. Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813 [TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation of TRIM58 in hepatocellular carcinoma and its potential clinical implication. Qiu X; Huang Y; Zhou Y; Zheng F Oncol Rep; 2016 Aug; 36(2):811-8. PubMed ID: 27373520 [TBL] [Abstract][Full Text] [Related]
5. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
6. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance. Yang L; Xu Q; Xie H; Gu G; Jiang J Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116 [TBL] [Abstract][Full Text] [Related]
7. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma. Cai L; Cai X Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma. Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602 [TBL] [Abstract][Full Text] [Related]
9. DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma. Lin JC; Wu YC; Wu CC; Shih PY; Wang WY; Chien YC Ann Hepatol; 2015; 14(4):494-504. PubMed ID: 26019036 [TBL] [Abstract][Full Text] [Related]
10. Prognostic implication of NQO1 overexpression in hepatocellular carcinoma. Lin L; Sun J; Tan Y; Li Z; Kong F; Shen Y; Liu C; Chen L Hum Pathol; 2017 Nov; 69():31-37. PubMed ID: 28964792 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis. Yang SZ; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG World J Gastroenterol; 2015 Jul; 21(27):8418-24. PubMed ID: 26217094 [TBL] [Abstract][Full Text] [Related]
12. High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy. Wubetu GY; Morine Y; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Ikemoto T; Saito YU; Imura S; Shimada M Anticancer Res; 2016 Feb; 36(2):757-62. PubMed ID: 26851035 [TBL] [Abstract][Full Text] [Related]
13. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence. Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786 [TBL] [Abstract][Full Text] [Related]
14. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma]. Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828 [TBL] [Abstract][Full Text] [Related]
15. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis. Shi XM; Teng F Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588 [TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037 [TBL] [Abstract][Full Text] [Related]
17. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues. Ajdarkosh H; Dadpay M; Yahaghi E; Pirzaman ER; Fayyaz AF; Darian EK; Mokarizadeh A Diagn Pathol; 2015 Aug; 10():135. PubMed ID: 26248880 [TBL] [Abstract][Full Text] [Related]
18. Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy. Sun FK; Sun Q; Fan YC; Gao S; Zhao J; Li F; Jia YB; Liu C; Wang LY; Li XY; Ji XF; Wang K J Gastroenterol Hepatol; 2016 Feb; 31(2):484-92. PubMed ID: 26313014 [TBL] [Abstract][Full Text] [Related]
19. 17-beta-hydroxysteroid dehydrogenase 13 inhibits the progression and recurrence of hepatocellular carcinoma. Chen J; Zhuo JY; Yang F; Liu ZK; Zhou L; Xie HY; Xu X; Zheng SS Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):220-226. PubMed ID: 29748147 [TBL] [Abstract][Full Text] [Related]
20. Cullin1 is up-regulated and associated with poor patients' survival in hepatocellular carcinoma. Liu W; Wang Y; Zhang C; Huang B; Bai J; Tian L Int J Clin Exp Pathol; 2015; 8(4):4001-7. PubMed ID: 26097587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]